Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Joyce de Langen

Joyce de Langen

Senior Solution Manager Pharmacovigilance

Connect with Joyce de Langen on LinkedIn
Follow Joyce de Langen on Twitter

About the author: I am a pharmacist by training. I joined Elsevier last month as Senior Solution Manager Pharmacovigilance. I am working in the pharmacovigilance and drug safety domain for more than 10 years. I started my professional career at the Netherlands Pharmacovigilance Centre for spontaneous adverse event reporting. After 6 years I teached pharmacotherapy and pharmacoepidemiology at the University of Utrecht and the last 5 years of my professional live I worked in the pharmaceutical industry (Abbott/AbbVie and Sanquin Plasma Products) in different roles within pharmacovigilance. Prior to working to Elsevier I was the qualified person for pharmacovigilance with Sanquin Plasma Products.

Posts by Joyce de Langen

Text Mining for Pharmacovigilance Purposes

Posted on July 7th, 2016 in Pharmacovigilance

Text mining, or text data mining, is the process of retrieving relevant information from large amounts of ‘unstructured’ text with the help of automated pattern learning. (more…)

The Role of Scientific Literature in Pharmacovigilance: Challenges and Solutions

Posted on May 6th, 2016 in Pharmacovigilance


After our recent webinar, Elsevier received several questions from attendees. During the next few weeks, we will discuss some of the questions in more detail.  (more…)

Data Transparency in Pharmacovigilance: European regulators give increased access to adverse drug reactions

Posted on March 16th, 2016 in Pharma R&D

On 17 December 2015, the European Medicines Agency (EMA) adopted the revised policy on access to Eudravigilance. According to the press release, the EMA will give increased access to reports of adverse reactions (more…)

EMA Yearly Update on MLM – highlights and next steps

Posted on January 19th, 2016 in Pharmacovigilance

EMA  Pharmacovigilance Programme Update Issue 6 – Preparing for Business Change

Since July 2014, EMA provides quarterly Pharmacovigilance Programme Updates to Marketing Authorisation Holders (MAHs). (more…)

  1. 1
  2. 2